Triptolide inhibits viability and migration while promotes apoptosis in nephroblastoma cells by regulation of miR-193b-3p.
Triptolide (TPL) is a potential anti-tumor natural compound. However, its role in nephroblastoma is poorly studied. Herein, we aimed to reveal the regulatory effects of TPL on human nephroblastoma cells (G-401 and WiT49) as well as the regulatory mechanism in G-401 cells. Effects of TPL on cell viability, migration and apoptosis of G-401 and WiT49 cells were measured by CCK-8 assay, Boyden Chamber, and flow cytometry/Western blot analysis, respectively. Expression of miR-193b-3p in TPL-treated G-401 and WiT49 cells was determined by RT-qPCR. Then, whether miR-193b-3p was the downstream factor of TPL was studied. Alteration of KLF4 expression in TPL-treated cells and the relationship between miR-193b-3p and KLF4 were assessed by Western blot analysis and luciferase reporter assay. Effects of abnormally expressed KLF4 on G-401 cells were also assessed. Finally, the involvements of PI3K/AKT and ERK pathways were measured by Western blot analysis. TPL reduced cell viability and migration while promoted apoptosis in G-401 and WiT49 cells. miR-193b-3p level was up-regulated by TPL stimulation, and TPL might function through regulation of miR-193b-3p. KLF4 expression was down-regulated by TPL, and KLF4 was proven to be a target gene of miR-193b-3p. TPL mediated the repressive roles in growth of nephroblastoma cells via KLF4 knockdown. Finally, we found phosphorylation of PI3K, AKT and ERK was inhibited by TPL, possibly through miR-193b-3p-mediated regulation of KLF4. TPL showed a tumor suppressive role in nephroblastoma cells via miR-193b-3p-mediated down-regulation of KLF4, along with inhibition of the PI3K/AKT and ERK pathways.